These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20676743)

  • 21. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
    Curigliano G; Criscitiello C
    J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GI perforation associated with bevacizumab.
    Yoon SS; Rivera R; Shah A; Ozden N
    Gastrointest Endosc; 2012 Jun; 75(6):1286-7. PubMed ID: 21862004
    [No Abstract]   [Full Text] [Related]  

  • 23. Combination of paclitaxel and bevacizumab in heavily pre-treated non-small-cell lung cancer (NSCLC) patients: a case series study on 15 patients.
    Le Moulec S; Hadoux J; Gontier E; Chargari C; Helissey C; Lamand V; Tanz R; Farace F; Vedrine L; Bonardel G; Soria JC; Besse B
    Bull Cancer; 2013 Dec; 100(12):30-7. PubMed ID: 24316967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rare case of isolated adrenal metastasis of invasive ductal breast carcinoma.
    Andjelić-Dekić N; Božović-Spasojević I; Milošević S; Matijašević M; Karadžić K
    Srp Arh Celok Lek; 2014; 142(9-10):597-601. PubMed ID: 25518541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of recurrent breast cancer with lung metastasis resection showing four disease-free years under trastuzumab treatment].
    Hanada N; Tomiyama N; Hori K; Kusano S; Yoshida Y; Kawata K; Uchino R; Sakashita N
    Gan To Kagaku Ryoho; 2010 Dec; 37(13):2905-7. PubMed ID: 21160267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A Case of Locally-Advanced Breast Cancer with Liver Metastasis, Treated with Mastectomy of the Primary Tumor after Chemotherapy].
    Kanada Y; Matsuzaki H; Kobayashi H; Suzuki K; Sawada H; Senba Y; Yoshioka T; Note H; Sato Y; Miyazaki A; Natsume T; Tanaka H; Maruyama T
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1509-11. PubMed ID: 26805079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of breast cancer liver metastases responding to lapatinib and capecitabine therapy].
    Sato T; Nakagawa T; Kuwayama T; Oda G; Sugimoto H; Ishiba T; Sugihara K
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2180-2. PubMed ID: 22202322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bevacizumab, paclitaxel and carboplatin for advanced ovarian cancer: low risk of gastrointestinal and cardiovascular toxicity.
    Abaid LN; Lopez KL; Micha JP; Rettenmaier MA; Brown JV; Goldstein BH
    Eur J Gynaecol Oncol; 2010; 31(3):308-11. PubMed ID: 21077475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC).
    Raez LE; Santos ES; Webb RT; Wade J; Brito RA; Karr M; Kennah A; Childs BH
    Cancer Chemother Pharmacol; 2013 Nov; 72(5):1103-10. PubMed ID: 24057043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Usefulness of bevacizumab with paclitaxel for advanced breast cancer - a case report].
    Morishita A; Mitsuhashi S; Fujisawa F; Hirano M; Kojima H
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):761-4. PubMed ID: 23863653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Two Cases of Bowel Perforation during Chemotherapy with Bevacizumab to Metastatic Rectal Cancer].
    Miyake Y; Ikeda K; Murakami M; Oka Y; Nezu R; Kurokawa E; Kikkawa N
    Gan To Kagaku Ryoho; 2015 Dec; 42 Suppl 1():75-8. PubMed ID: 26809419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of intragastric wall abscess formation during bevacizumab combined chemotherapy].
    Mori A; Kogawa T; Arihara Y; Abe M; Tamura F; Abe S; Kukitsu T; Ihara H; Sumiyoshi T; Yoshizaki N; Kondou H; Tsuji Y
    Nihon Shokakibyo Gakkai Zasshi; 2013 May; 110(5):846-51. PubMed ID: 23648541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early-onset brain metastases in a breast cancer patient after pathological complete response to neoadjuvant chemotherapy.
    Shimada K; Ishikawa T; Yoneyama S; Kita K; Narui K; Sugae S; Shimizu D; Tanabe M; Sasaki T; Chishima T; Ichikawa Y; Endo I
    Anticancer Res; 2013 Nov; 33(11):5119-21. PubMed ID: 24222158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer.
    Gianni L; Romieu GH; Lichinitser M; Serrano SV; Mansutti M; Pivot X; Mariani P; Andre F; Chan A; Lipatov O; Chan S; Wardley A; Greil R; Moore N; Prot S; Pallaud C; Semiglazov V
    J Clin Oncol; 2013 May; 31(14):1719-25. PubMed ID: 23569311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An unusual case of bowel perforation.
    Lazarescu RE; Bohm K
    BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24957587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrobulbar optic neuritis in a bevacizumab-treated patient with metastatic breast cancer.
    Zhou Y; Zhang Y; Yang X; Fan L; Jiang J
    Breast J; 2012 Sep; 18(5):502-3. PubMed ID: 22891618
    [No Abstract]   [Full Text] [Related]  

  • 37. Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44).
    Gerber B; Loibl S; Eidtmann H; Rezai M; Fasching PA; Tesch H; Eggemann H; Schrader I; Kittel K; Hanusch C; Kreienberg R; Solbach C; Jackisch C; Kunz G; Blohmer JU; Huober J; Hauschild M; Nekljudova V; Untch M; von Minckwitz G;
    Ann Oncol; 2013 Dec; 24(12):2978-84. PubMed ID: 24136883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case report-bleeding from the ulcer of wound for mastectomy after postoperative chemotherapy with bevacizumab for Sigmoid colon cancer].
    Tsumuraya M; Fujita M; Muroi H; Sugawara A; Tsubaki M; Kato H
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1869-71. PubMed ID: 22083200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modified resistance to chemotherapy and trastuzumab by bevacizumab in locally recurrent breast cancer.
    Farhat MH; El-Saghir NS; Shamseddine AI
    Breast; 2009 Feb; 18(1):66-8. PubMed ID: 19013064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bevacizumab and advanced-stage ovarian cancer. Yet another oncological indication, but still best to avoid using this drug.
    Prescrire Int; 2013 Mar; 22(136):64-7. PubMed ID: 23593688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.